Greenlane CEO awarded 1.12M options at $3.84 plus 40K RS
Rhea-AI Filing Summary
Greenlane Holdings (GNLN) insider transaction: The Chief Executive Officer reported equity grants, including 40,000 shares of Class A common stock acquired at $0.00 as restricted stock and a grant of 1,120,000 stock options on 10/20/2025.
The options carry an exercise price of $3.84 (equal to the closing price on October 17, 2025), vest in full upon grant, and expire on 10/20/2030. Following these transactions, the CEO beneficially owns 40,016 Class A shares directly. The filing notes the option grant comes from the company’s 3,000,000-share ESOP distribution approved by the Board on October 19, 2025.
Positive
- None.
Negative
- None.
Insights
Large CEO option grant vests immediately; routine Form 4.
Greenlane Holdings reported a CEO grant of 1,120,000 stock options at an exercise price of $3.84 on 10/20/2025. The grant vests in full upon grant and expires on 10/20/2030. The CEO also received 40,000 restricted shares at $0.00.
The exercise price matches the closing price on 10/17/2025, and the allocation is drawn from a 3,000,000-share ESOP distribution approved on 10/19/2025. After the transactions, direct beneficial ownership stands at 40,016 Class A shares. Actual market impact depends on future exercise and sale decisions permitted under plan terms.
Subsequent filings may provide additional context on aggregate dilution and remaining ESOP capacity; this entry records the insider’s grants and current holdings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 1,120,000 | $0.001 | $1K |
| Grant/Award | Class A Common Stock | 40,000 | $0.00 | -- |
Footnotes (1)
- Represents shares of restricted stock issued as compensatory equity under the Company's 2019 Equity Incentive Plan. The exercise price equals the closing price of Greenlane Holdings, Inc. Class A Common Stock on October 17, 2025. Options vest in full upon grant in consideration of executive service and expire five (5) years from the grant date, unless earlier terminate dunder Plan terms. The option allocation is from the Company's 3,000,000 share ESOP distribution approved and ratified by the Board on October 19, 2025.